RG
Redmile Group Portfolio holdings
AUM
$940M
1-Year Return
75.78%
This Quarter Return
-5.25%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$7.1B
AUM Growth
-$1.16B
(-14%)
Cap. Flow
-$264M
Cap. Flow
% of AUM
-3.72%
Top 10 Holdings %
Top 10 Hldgs %
41.94%
Holding
104
New
17
Increased
24
Reduced
34
Closed
18
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$136M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$130M |
| 3 |
Medtronic
MDT
|
$116M |
| 4 |
LivaNova
LIVN
|
$82.6M |
| 5 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$80M |
Top Sells
| 1 |
AbbVie
ABBV
|
$149M |
| 2 |
Gilead Sciences
GILD
|
$133M |
| 3 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$107M |
| 4 |
Beam Therapeutics
BEAM
|
$99.7M |
| 5 |
Sanofi
SNY
|
$96.4M |
Sector Composition
| 1 | Healthcare | 95.05% |
| 2 | Financials | 0.83% |
| 3 | Consumer Staples | 0.3% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
LAVA Therapeutics
LVTX
$41.3M
| $42.9M | 0.6% |
+2,824,409
| New | +$42.9M |
|
52
UnitedHealth
UNH
$286B
| $42.6M | 0.6% |
114,376
-110,263
| -49% | -$41M |
|
|
BCEL
53
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $38.2M | 0.54% |
2,490,568
+14,500
| +0.6% | +$222K |
|
|
AMED
54
DELISTED
Amedisys
AMED
| $35.2M | 0.5% |
132,980
-500
| -0.4% | -$132K |
|
|
ACHL
55
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $34.6M | 0.49% |
+2,088,089
| New | +$34.6M |
|
56
Avita Medical
RCEL
$115M
| $33.1M | 0.47% |
1,668,327
-39,059
| -2% | -$774K |
|
|
CTLT
57
DELISTED
CATALENT, INC.
CTLT
| $32.8M | 0.46% |
311,619
-2,900
| -0.9% | -$305K |
|
58
Zymeworks
ZYME
$1.14B
| $31.1M | 0.44% |
985,700
-102,600
| -9% | -$3.24M |
|
|
PPD
59
DELISTED
PPD, Inc. Common Stock
PPD
| $31.1M | 0.44% |
821,092
-2,100
| -0.3% | -$79.5K |
|
|
HOOK
60
DELISTED
HOOKIPA Pharma
HOOK
| $24.8M | 0.35% |
184,290
| – | – |
|
61
Immatics
IMTX
$761M
| $23.3M | 0.33% |
2,082,814
+14,513
| +0.7% | +$163K |
|
62
Ardelyx
ARDX
$1.57B
| $23.3M | 0.33% |
3,514,100
| – | – |
|
|
GRTS
63
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $23.1M | 0.33% |
2,448,158
-611,636
| -20% | -$5.77M |
|
64
Bioventus
BVS
$481M
| $22.9M | 0.32% |
+1,500,000
| New | +$22.9M |
|
|
ITMR
65
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $22M | 0.31% |
918,900
+207,400
| +29% | +$4.97M |
|
|
ONEM
66
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $22M | 0.31% |
562,314
-2,746,880
| -83% | -$107M |
|
67
InnovAge Holding
INNV
$512M
| $21.9M | 0.31% |
+850,000
| New | +$21.9M |
|
68
Stereotaxis
STXS
$264M
| $21.8M | 0.31% |
3,241,603
+138,276
| +4% | +$929K |
|
69
The Beauty Health Co
SKIN
$260M
| $21.4M | 0.3% |
1,982,749
+982,749
| +98% | +$10.6M |
|
70
Cytosorbents Corp
CTSO
$60.6M
| $18.5M | 0.26% |
2,127,631
+73,500
| +4% | +$638K |
|
71
Quanterix
QTRX
$211M
| $17.5M | 0.25% |
+300,000
| New | +$17.5M |
|
|
PROF
72
Profound Medical
PROF
$124M
| $17M | 0.24% |
845,674
+20,477
| +2% | +$412K |
|
|
KA
73
DELISTED
Kineta, Inc. Common Stock
KA
| $11.1M | 0.16% |
87,286
| – | – |
|
74
uniQure
QURE
$985M
| $9.57M | 0.13% |
284,160
-744,738
| -72% | -$25.1M |
|
75
Dynavax Technologies
DVAX
$1.18B
| $8.68M | 0.12% |
882,814
-334,030
| -27% | -$3.28M |
|